Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis
- PMID: 342639
- DOI: 10.1093/infdis/137.2.131
Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis
Abstract
In a randomized, double-blind multicenter trial, 284 patients and 282 staff members of renal dialysis units who lacked detectable hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs) were randomly assigned to receive two 3-ml injections of immune serum globulin with high, intermediate, or low titers of anti-HBs four months apart. The incidence of infection with hepatitis B and of development of HBsAg was significantly lower in both patients and staff who received the high-titer material than in subjects who received the low-titer preparation eight but not 12 months after randomization (P less than 0.01 for patients and P less than 0.04 for staff, low-titer vs. high-titer at eight months). The high-titer hepatitis B immune globulin preparation did not appear to affect the severity of the cases of hepatitis that did occur, the proportion of subjects who developed persistent antigenemia, or the magnitude or timing of primary anti-HBs responses.
Similar articles
-
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis.N Engl J Med. 1975 Nov 20;293(21):1063-7. doi: 10.1056/NEJM197511202932103. N Engl J Med. 1975. PMID: 1101066 Clinical Trial.
-
Hepatitis B in haemodialysis: vaccination against HBS antigen.Proc Eur Dial Transplant Assoc. 1981;18:231-40. Proc Eur Dial Transplant Assoc. 1981. PMID: 7036150 Clinical Trial.
-
[Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].Zhonghua Gan Zang Bing Za Zhi. 2013 Aug;21(8):580-3. doi: 10.3760/cma.j.issn.1007-3418.2013.08.005. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24119736 Clinical Trial. Chinese.
-
[Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].Lijec Vjesn. 1989 Nov;111(11):400-4. Lijec Vjesn. 1989. PMID: 2534601 Croatian.
-
Passive immunization against hepatitis B: a review of recent studies and comment on current aspects of control.Am J Epidemiol. 1978 Feb;107(2):77-86. doi: 10.1093/oxfordjournals.aje.a112520. Am J Epidemiol. 1978. PMID: 341692 Review.
Cited by
-
Antiviral agents: action and clinical use.Drugs. 1979 Nov;18(5):354-76. doi: 10.2165/00003495-197918050-00002. Drugs. 1979. PMID: 92398 Review.
-
Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen.Infect Immun. 1983 Feb;39(2):565-8. doi: 10.1128/iai.39.2.565-568.1983. Infect Immun. 1983. PMID: 6832810 Free PMC article.
-
Cytotoxicity of human peripheral blood T-lymphocyte clones activated by hepatitis B virus surface antigen.Experientia. 1985 Dec 15;41(12):1579-84. doi: 10.1007/BF01964817. Experientia. 1985. Retraction in: Experientia. 1990 May 15;46(5):preceding 429. PMID: 2416588 Retracted.
-
Clinical practice guideline management of blood borne viruses within the haemodialysis unit.BMC Nephrol. 2019 Oct 28;20(1):388. doi: 10.1186/s12882-019-1529-1. BMC Nephrol. 2019. PMID: 31656166 Free PMC article.
-
Use of immunoglobulin with high content of antibody to hepatitis B surface antigen (anti-HBs). Working Party on the Clinical Use of Specific Immunoglobulin in Hepatitis B.Br Med J (Clin Res Ed). 1982 Oct 2;285(6346):951-4. doi: 10.1136/bmj.285.6346.951. Br Med J (Clin Res Ed). 1982. PMID: 6811086 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
